Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy
Global Metrics

PDL BioPharma Total Assets 2006-2018 | PDLI

PDL BioPharma total assets from 2006 to 2018. Total assets can be defined as the sum of all assets on a company's balance sheet.
PDL BioPharma Annual Total Assets
(Millions of US $)
2018 $964
2017 $1,243
2016 $1,215
2015 $1,012
2014 $962
2013 $544
2012 $280
2011 $269
2010 $317
2009 $338
2008 $191
2007 $1,192
2006 $1,142
2005 $1,163
PDL BioPharma Quarterly Total Assets
(Millions of US $)
Q4 2018 $964
Q3 2018 $984
Q2 2018 $946
Q1 2018 $1,100
Q4 2017 $1,243
Q3 2017 $1,224
Q2 2017 $1,302
Q1 2017 $1,238
Q4 2016 $1,215
Q3 2016 $1,216
Q2 2016 $1,049
Q1 2016 $1,055
Q4 2015 $1,012
Q3 2015 $1,021
Q2 2015 $996
Q1 2015 $1,114
Q4 2014 $962
Q3 2014 $980
Q2 2014 $916
Q1 2014 $853
Q4 2013 $544
Q3 2013 $430
Q2 2013 $401
Q1 2013 $313
Q4 2012 $280
Q3 2012 $250
Q2 2012 $260
Q1 2012 $235
Q4 2011 $269
Q3 2011 $271
Q2 2011 $284
Q1 2011 $249
Q4 2010 $317
Q3 2010 $258
Q2 2010 $272
Q1 2010 $358
Q4 2009 $338
Q3 2009 $264
Q2 2009 $218
Q1 2009 $219
Q4 2008 $191
Q3 2008 $718
Q2 2008 $654
Q1 2008 $1,118
Q4 2007 $1,192
Q3 2007 $1,163
Q2 2007 $1,184
Q1 2007 $1,121
Q4 2006 $1,142
Q3 2006 $1,197
Q2 2006 $1,180
Q1 2006 $1,173
Q4 2005 $1,163
Q3 2005 $1,177
Q2 2005 $1,055
Q1 2005 $1,049
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.460B $0.198B
Protein Design Labs Inc. is a biopharmaceutical company focused on the research, development and commercialization of novel therapies for inflammation and autoimmune diseases, acute cardiac conditions and cancer. PDL markets several biopharmaceutical products in the United States through its hospital sales force and wholly-owned subsidiary, ESP Pharma, Inc. As a leader in the development of humanized antibodies, PDL has licensed its patents to numerous pharmaceutical and biotechnology companies, some of which are now paying royalties on net sales of licensed products.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $116.179B 12.96
Gilead Sciences (GILD) United States $81.339B 10.35
Celgene (CELG) United States $61.913B 11.45
Vertex Pharmaceuticals (VRTX) United States $46.409B 62.17
Illumina (ILMN) United States $45.392B 53.98
Regeneron Pharmaceuticals (REGN) United States $42.814B 19.89
Biogen (BIIB) United States $42.629B 8.26
Alexion Pharmaceuticals (ALXN) United States $29.098B 18.03
Incyte (INCY) United States $18.285B 170.68
BioMarin Pharmaceutical (BMRN) United States $15.706B 0.00
Seattle Genetics (SGEN) United States $11.880B 0.00
Exact Sciences (EXAS) United States $11.193B 0.00
Bio-Rad Laboratories (BIO.B) United States $9.441B 53.86
Alnylam Pharmaceuticals (ALNY) United States $8.981B 0.00
QIAGEN (QGEN) Netherlands $8.890B 29.42
Sarepta Therapeutics (SRPT) United States $8.716B 0.00
Bluebird Bio (BLUE) United States $8.058B 0.00
BeiGene (BGNE) Cayman Islands $7.395B 0.00
Bio-Techne Corp (TECH) United States $7.264B 48.94
Exelixis (EXEL) United States $6.969B 16.24
Guardant Health (GH) United States $6.789B 0.00
Moderna (MRNA) United States $6.251B 0.00
Amarin (AMRN) Ireland $5.654B 0.00
Alkermes (ALKS) Ireland $5.299B 0.00
Galapagos (GLPG) Belgium $5.096B 0.00
Ascendis Pharma (ASND) Denmark $5.005B 0.00
Array BioPharma (ARRY) United States $4.908B 0.00
Horizon Pharma Public (HZNP) Ireland $4.553B 14.67
Spark Therapeutics (ONCE) United States $4.290B 0.00
ARGENX SE-ADR (ARGX) Netherlands $4.039B 0.00
ACADIA Pharmaceuticals (ACAD) United States $3.755B 0.00
Blueprint Medicines (BPMC) United States $3.465B 0.00
China Biologic Products (CBPO) China $3.434B 21.28
Immunomedics (IMMU) United States $3.332B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.315B 0.00
Intercept Pharmaceuticals (ICPT) United States $3.262B 0.00
Allogene Therapeutics (ALLO) United States $3.104B 0.00
Amicus Therapeutics (FOLD) United States $2.966B 0.00
MorphoSys AG Unsponsored ADR (MOR) Germany $2.890B 0.00
Global Blood Therapeutics (GBT) United States $2.789B 0.00
Reata Pharmaceuticals (RETA) United States $2.594B 0.00
Repligen (RGEN) United States $2.587B 79.61
Mirati Therapeutics (MRTX) United States $2.583B 0.00
Genomic Health (GHDX) United States $2.560B 65.44
Ligand Pharmaceuticals (LGND) United States $2.553B 19.06
Akcea Therapeutics (AKCA) United States $2.491B 0.00
Emergent Biosolutions (EBS) United States $2.475B 20.65
Myriad Genetics (MYGN) United States $2.425B 24.70
UniQure (QURE) Netherlands $2.387B 0.00
Acceleron Pharma (XLRN) United States $2.283B 0.00
Biohaven Pharmaceutical Holding (BHVN) United States $2.251B 0.00
Halozyme Therapeutics (HALO) United States $2.247B 0.00
MyoKardia (MYOK) United States $2.190B 0.00
Insmed (INSM) United States $2.187B 0.00
Arena Pharmaceuticals (ARNA) United States $2.138B 0.00
REGENXBIO (RGNX) United States $2.105B 21.97
Nabriva Therapeutics AG (NBRV) Ireland $2.098B 0.00
Medicines (MDCO) United States $1.963B 0.00
AnaptysBio (ANAB) United States $1.921B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $1.861B 0.00
Denali Therapeutics (DNLI) United States $1.853B 0.00
NeoGenomics (NEO) United States $1.774B 144.31
Atara Biotherapeutics (ATRA) United States $1.728B 0.00
Zai Lab Unsponsored ADR (ZLAB) China $1.691B 0.00
Myovant Sciences (MYOV) United Kingdom $1.643B 0.00
Audentes Therapeutics (BOLD) United States $1.575B 0.00
Allakos (ALLK) United States $1.565B 0.00
Puma Biotechnology (PBYI) United States $1.503B 0.00
WAVE Life Sciences (WVE) Singapore $1.434B 0.00
Orchard Therapeutics Sponsored ADR (ORTX) United Kingdom $1.416B 0.00
Innoviva (INVA) United States $1.389B 3.83
GOSSAMER BIO (GOSS) United States $1.367B 0.00
Aimmune Therapeutics (AIMT) United States $1.336B 0.00
Clovis Oncology (CLVS) United States $1.313B 0.00
Rubius Therapeutics (RUBY) United States $1.289B 0.00
Cambrex (CBM) United States $1.285B 13.84
Momenta Pharmaceuticals (MNTA) United States $1.278B 0.00
ALECTOR INC (ALEC) United States $1.234B 0.00
Apellis Pharmaceuticals (APLS) United States $1.194B 0.00
Lion Biotechnologies (IOVA) United States $1.179B 0.00
Editas Medicine (EDIT) United States $1.110B 0.00
Codexis (CDXS) United States $1.063B 0.00
Fate Therapeutics (FATE) United States $1.049B 0.00
Epizyme (EPZM) United States $1.038B 0.00
Rhythm Pharmaceuticals (RYTM) United States $1.030B 0.00
InflaRx (IFRX) Germany $1.023B 0.00
RA PHARMCTL INC (RARX) United States $1.007B 0.00
Coherus BioSciences (CHRS) United States $0.992B 0.00
Clementia Pharmaceuticals (CMTA) Canada $0.990B 0.00
Autolus Therapeutics Sponsored ADR (AUTL) United Kingdom $0.979B 0.00
Retrophin (RTRX) United States $0.929B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.926B 37.43
Deciphera Pharmaceuticals (DCPH) United States $0.914B 0.00
Sangamo Therapeutics (SGMO) United States $0.909B 0.00
Dicerna Pharmaceuticals (DRNA) United States $0.907B 0.00
Alder BioPharmaceuticals (ALDR) United States $0.887B 0.00
Kiniksa Pharmaceuticals (KNSA) Bermuda $0.867B 0.00
Athenex (ATNX) United States $0.822B 0.00
Principia Biopharma (PRNB) United States $0.806B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.799B 0.00
Vericel (VCEL) United States $0.796B 0.00
Eidos Therapeutics (EIDX) United States $0.783B 0.00
ANI Pharmaceuticals (ANIP) United States $0.782B 14.31
Inotek Pharmaceuticals (RCKT) United States $0.758B 0.00
Intellia Therapeutics (NTLA) United States $0.731B 0.00
Sorrento Therapeutics (SRNE) United States $0.726B 0.00
Cellectis (CLLS) France $0.724B 0.00
Cara Therapeutics (CARA) United States $0.724B 0.00
Nightstar Therapeutics Sponsored ADR (NITE) United Kingdom $0.711B 0.00
Revance Therapeutics (RVNC) United States $0.681B 0.00
Intra-Cellular Therapies (ITCI) United States $0.664B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.661B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.659B 0.00
Osiris Therapeutics (OSIR) United States $0.657B 0.00
Heska (HSKA) United States $0.635B 56.96
Acorda Therapeutics (ACOR) United States $0.625B 8.10
Magenta Therapeutics (MGTA) United States $0.621B 0.00
Twist Bioscience (TWST) United States $0.617B 0.00
Synthorx (THOR) United States $0.599B 0.00
Viking Therapeutics (VKTX) United States $0.595B 0.00
NuCana Sponsored ADR (NCNA) United Kingdom $0.581B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.581B 0.00
ObsEva SA (OBSV) Switzerland $0.575B 0.00
Kura Oncology (KURA) United States $0.568B 0.00
Zealand Pharma (ZEAL) Denmark $0.551B 6.13
Stemline Therapeutics (STML) United States $0.539B 0.00
G1 THERAPEUTICS (GTHX) United States $0.535B 0.00
Arvinas (ARVN) United States $0.510B 0.00
MeiraGTx Holdings (MGTX) United States $0.501B 0.00
Arcus Biosciences (RCUS) United States $0.498B 0.00
Prothena (PRTA) Ireland $0.490B 0.00
UROGEN PHARMA (URGN) Israel $0.488B 0.00
Scholar Rock Holding (SRRK) United States $0.485B 0.00
Cytokineticsorporated (CYTK) United States $0.480B 0.00
Zymeworks (ZYME) Canada $0.472B 0.00
CytomX Therapeutics (CTMX) United States $0.470B 0.00
Five Prime Therapeutics (FPRX) United States $0.464B 0.00
Mesoblast (MESO) Australia $0.457B 0.00
Dynavax Technologies (DVAX) United States $0.454B 0.00
DBV Technologies (DBVT) France $0.454B 0.00
AVROBIO (AVRO) United States $0.436B 0.00
Replimune (REPL) United States $0.435B 0.00
Axsome Therapeutics (AXSM) United States $0.433B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.422B 0.00
Senesco Technologies (ELOX) United States $0.420B 0.00
Anika Therapeutics (ANIK) United States $0.418B 15.82
Achillion Pharmaceuticals (ACHN) United States $0.406B 0.00
MannKind (MNKD) United States $0.399B 0.00
BeyondSpring (BYSI) United States $0.398B 0.00
XBiotech (XBIT) United States $0.394B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.380B 0.00
Agenus (AGEN) United States $0.378B 0.00
Sinovac Biotech (SVA) China $0.371B 0.00
Solid Biosciences (SLDB) United States $0.363B 0.00
BioDelivery Sciences (BDSI) United States $0.363B 0.00
Krystal Biotech (KRYS) United States $0.361B 0.00
Abeona Therapeutics (ABEO) United States $0.361B 0.00
Inovio Pharmaceuticals (INO) United States $0.353B 0.00
Kadmon Holdings (KDMN) United States $0.352B 0.00
Adverum Biotechnologies (ADVM) United States $0.348B 0.00
UNITY Biotechnology (UBX) $0.343B 0.00
Urovant Sciences (UROV) United States $0.342B 0.00
Albireo Pharma (ALBO) United States $0.342B 0.00
MediciNova (MNOV) United States $0.337B 0.00
STEALTH BIOTHER (MITO) United States $0.335B 0.00
OSMOTICA PHARM (OSMT) United States $0.334B 0.00
Gritstone Oncology (GRTS) United States $0.332B 0.00
AC Immune SA (ACIU) Switzerland $0.322B 0.00
Kezar Life Sciences (KZR) United States $0.322B 0.00
Kindred Biosciences (KIN) United States $0.321B 0.00
Protagonist Therapeutics (PTGX) United States $0.321B 0.00
Geron (GERN) United States $0.315B 0.00
Cellular Biomedicine (CBMG) United States $0.303B 0.00
Syros Pharmaceuticals (SYRS) United States $0.302B 0.00
Aduro Biotech (ADRO) United States $0.293B 0.00
Merus (MRUS) Netherlands $0.292B 0.00
Constellation Pharmaceuticals (CNST) United States $0.290B 0.00
Gamida Cell (GMDA) Israel $0.289B 0.00
Strongbridge Biopharma (SBBP) United States $0.279B 0.00
Biofrontera AG Sponsored ADR (BFRA) Germany $0.276B 0.00
Enochian BioSciences (ENOB) United States $0.272B 0.00
Eiger BioPharmaceuticals (EIGR) United States $0.268B 0.00
Evelo Biosciences (EVLO) United States $0.256B 0.00
Seres Therapeutics (MCRB) United States $0.255B 0.00
Kala Pharmaceuticals (KALA) United States $0.251B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.248B 0.00
Sutro Biopharma (STRO) United States $0.245B 0.00
Kodiak Sciences (KOD) United States $0.243B 0.00
Avid Bioservices (CDMO) United States $0.241B 0.00
Verastem (VSTM) United States $0.239B 0.00
TOCAGEN INC (TOCA) United States $0.239B 0.00
Novavax (NVAX) United States $0.239B 0.00
Cerecor (CERC) United States $0.238B 0.00
Kamada (KMDA) Israel $0.235B 10.60
ResTORbio (TORC) United States $0.228B 0.00
Spero Therapeutics (SPRO) United States $0.227B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.223B 0.00
Athersys (ATHX) United States $0.223B 0.00
Intec Pharma (NTEC) Israel $0.220B 0.00
ChromaDex (CDXC) United States $0.218B 0.00
Axovant Sciences (AXGT) United Kingdom $0.216B 0.00
LogicBio Therapeutics (LOGC) United States $0.214B 0.00
Mersana Therapeutics (MRSN) United States $0.212B 0.00
Celcuity (CELC) United States $0.209B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.208B 0.00
Proteostasis Therapeutics (PTI) United States $0.208B 0.00
Celyad SA (CYAD) Belgium $0.203B 0.00
Arbutus Biopharma (ABUS) Canada $0.198B 0.00
Synlogic (SYBX) United States $0.193B 0.00
VBI Vaccines (VBIV) United States $0.192B 0.00
OvaScience (MLND) United States $0.190B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.187B 0.00
Compugen (CGEN) Israel $0.186B 0.00
Menlo Therapeutics (MNLO) United States $0.180B 0.00
Liquidia Technologies (LQDA) United States $0.173B 0.00
PHASEBIO PHARMA (PHAS) United States $0.165B 0.00
Cue Biopharma (CUE) United States $0.165B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.158B 0.00
Trevena (TRVN) United States $0.157B 0.00
ADMA Biologics Inc (ADMA) United States $0.153B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.153B 0.00
Erytech Pharma SA Sponsored ADR (ERYP) France $0.149B 0.00
Aptinyx (APTX) United States $0.146B 0.00
Anavex Life Sciences (AVXL) United States $0.146B 0.00
Allena Pharmaceuticals (ALNA) United States $0.145B 0.00
BioXcel Therapeutics (BTAI) United States $0.144B 0.00
Eton Pharmaceuticals (ETON) United States $0.137B 0.00
Chiasma (CHMA) United States $0.135B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.134B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.132B 0.00
Unum Therapeutics (UMRX) United States $0.132B 0.00
Cohbar (CWBR) United States $0.132B 0.00
Organovo Holdings (ONVO) United States $0.129B 0.00
Enzo Biochem (ENZ) United States $0.121B 0.00
Equillium (EQ) United States $0.118B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.118B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.117B 0.00
XOMA (XOMA) United States $0.114B 0.00
Pluristem Therapeutics (PSTI) Israel $0.113B 0.00
Fortress Biotech (FBIO) United States $0.105B 0.00
Selecta Biosciences (SELB) United States $0.105B 0.00
Checkpoint Therapeutics (CKPT) United States $0.104B 0.00
Catalyst Biosciences (CBIO) United States $0.102B 0.00
Neothetics (EVFM) United States $0.100B 0.00
Mustang Bio (MBIO) United States $0.100B 0.00
NantKwest (NK) United States $0.100B 0.00
Signal Genetics (MGEN) United States $0.098B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.094B 0.00
ARAVIVE, INC (ARAV) United States $0.093B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.092B 0.00
Oncobiologics (OTLK) United States $0.092B 0.00
Aptose Biosciences (APTO) Canada $0.091B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.089B 0.00
Provention Bio (PRVB) United States $0.089B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $0.088B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.085B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.084B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.084B 0.00
Cocrystal Pharma (COCP) United States $0.084B 93.33
AVEO Pharmaceuticals (AVEO) United States $0.081B 0.00
VTv Therapeutics (VTVT) United States $0.080B 0.00
Orgenesis (ORGS) United States $0.078B 0.00
INMUNE BIO INC (INMB) United States $0.078B 0.00
Sienna Biopharmaceuticals (SNNA) United States $0.077B 0.00
Applied Genetic Technologies (AGTC) United States $0.076B 0.00
Idera Pharmaceuticals (IDRA) United States $0.075B 0.00
Tiziana Life Sciences Sponsored ADR (TLSA) United Kingdom $0.075B 0.00
Alimera Sciences (ALIM) United States $0.074B 0.00
OVID THERAPEUTC (OVID) United States $0.073B 0.00
NewLink Genetics (NLNK) United States $0.071B 0.00
Cidara Therapeutics (CDTX) United States $0.071B 0.00
Prima BioMed (IMMP) Australia $0.070B 0.00
SESEN BIO, INC (SESN) United States $0.068B 0.00
AEterna Zentaris (AEZS) United States $0.068B 12.94
Proteon Therapeutics (PRTO) United States $0.064B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.063B 0.00
Ophthotech (OPHT) United States $0.063B 0.00
Eyenovia (EYEN) United States $0.062B 0.00
Celldex Therapeutics (CLDX) United States $0.061B 0.00
Zosano Pharma (ZSAN) United States $0.061B 0.00
Vascular Biogenics (VBLT) Israel $0.058B 0.00
Vaccinex (VCNX) United States $0.056B 0.00
Alcobra (ARCT) United States $0.056B 0.00
ScPharmaceuticals (SCPH) United States $0.055B 0.00
VistaGen Therapeutics (VTGN) United States $0.055B 0.00
Clearside Biomedical (CLSD) United States $0.053B 0.00
INNOVATE BIOPHARMACEUTICALS, INC (INNT) United States $0.053B 0.00
ANCHIANO THERAP (ANCN) Israel $0.052B 0.00
Arsanis (XFOR) United States $0.050B 0.00
Bellerophon Therapeutics (BLPH) United States $0.050B 0.00
Evogene (EVGN) Israel $0.049B 0.00
Entera Bio (ENTX) Israel $0.048B 0.00
Bionano Genomics (BNGO) United States $0.048B 0.00
Curis (CRIS) United States $0.047B 0.00
DiaMedica Therapeutics (DMAC) United States $0.047B 0.00
VIVUS (VVUS) United States $0.046B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.045B 0.00
TRACON Pharmaceuticals (TCON) United States $0.044B 0.00
AquaBounty Technologies (AQB) United States $0.043B 0.00
Leap Therapeutics (LPTX) United States $0.042B 0.00
Aptevo Therapeutics (APVO) United States $0.039B 0.00
Celsion (CLSN) United States $0.039B 0.00
AZURRX BIOPHARM (AZRX) United States $0.038B 0.00
Moleculin Biotech (MBRX) United States $0.038B 0.00
Caladrius Biosciences (CLBS) United States $0.036B 0.00
BiondVax Pharmaceuticals (BVXV) Israel $0.035B 0.00
OncoMed Pharmaceuticals (OMED) United States $0.034B 0.00
Advaxis (ADXS) United States $0.033B 0.00
Oncolytics Biotech (ONCY) Canada $0.033B 0.00
Motif Bio Plc (MTFB) United States $0.033B 0.00
Sophiris Bio (SPHS) United States $0.033B 0.00
OncoSec Medical (ONCS) United States $0.032B 0.00
Adial Pharmaceuticals (ADIL) United States $0.029B 0.00
GTx (GTXI) United States $0.029B 0.00
Aileron Therapeutics (ALRN) United States $0.029B 0.00
GENPREX INC (GNPX) United States $0.027B 0.00
Vical (VICL) United States $0.027B 0.00
Galena Biopharma (SLS) United States $0.026B 0.00
CytRx (CYTR) United States $0.025B 0.00
IMMURON LTD (IMRN) Australia $0.025B 0.00
Fibrocell Science Inc (FCSC) United States $0.024B 0.00
Titan Pharmaceuticals (TTNP) United States $0.024B 0.00
Novelion Therapeutics (NVLN) Canada $0.023B 0.00
Aytu Bioscience (AYTU) United States $0.022B 0.00
Benitec Biopharma (BNTC) Australia $0.022B 0.00
Dare Bioscience (DARE) United States $0.019B 0.00
Prana Biotechnology (PRAN) Australia $0.019B 0.00
Cleveland BioLabs (CBLI) United States $0.018B 0.00
Novogen (KZIA) Australia $0.017B 0.00
Gemphire Therapeutics (GEMP) United States $0.017B 0.00
ATyr Pharma (LIFE) United States $0.017B 0.00
Soligenix (SNGX) United States $0.016B 0.00
Apricus Biosciences (SEEL) United States $0.016B 0.00
RestorGenex (DFFN) United States $0.016B 0.00
TrovaGene (TROV) United States $0.016B 0.00
Therapix Biosciences (TRPX) Israel $0.015B 7.37
Genetic Technologies (GENE) Australia $0.014B 0.00
Alliqua BioMedical (ALQA) United States $0.013B 0.00
Edge Therapeutics (PDSB) United States $0.012B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.012B 0.00
Neuralstem (CUR) United States $0.011B 0.00
Pulmatrix (PULM) United States $0.011B 0.00
MYOS RENS Technology (MYOS) United States $0.010B 0.00
Vital Therapies (VTL) United States $0.009B 0.00
Flex Pharma (FLKS) United States $0.008B 0.00
Histogenics (HSGX) United States $0.007B 0.00
ARCA Biopharma (ABIO) United States $0.007B 0.00
Stellar Biotechnologies (SBOT) United States $0.006B 0.00
Cellect Biotechnology (APOP) Israel $0.005B 0.00
ContraVir Pharmaceuticals Inc (CTRV) United States $0.004B 0.00
Cytori Therapeutics Inc (CYTX) United States $0.003B 0.00
Tenax Therapeutics (TENX) United States $0.003B 0.00
HOTH THERAPEUTC (HOTH) United States $0.000B 0.00